Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,918 | 4,334 | 3,137 | 3,906 | 4,861 |
| Marketable Securities | 1,949 | 1,926 | 2,315 | 3,175 | 3,154 |
| Other current assets | 72 | 0 | 0 | 0 | 0 |
| TOTAL | $6,164 | $6,373 | $5,604 | $7,112 | $8,262 |
| Non-Current Assets | |||||
| Intangibles | 220 | 223 | 238 | 241 | 244 |
| Other Non-Current Assets | 0 | 56 | 58 | 59 | 61 |
| TOTAL | $220 | $280 | $296 | $300 | $305 |
| Total Assets | $6,385 | $6,653 | $5,900 | $7,412 | $8,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 636 | 978 | 1,113 | 1,584 | 973 |
| TOTAL | $708 | $1,050 | $1,185 | $1,656 | $1,045 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $668 | $686 | $704 | $722 | $740 |
| Total Liabilities | $1,376 | $1,735 | $1,889 | $2,378 | $1,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,318 | 9,401 | 4,484 | 4,484 | 4,484 |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -18,611 | -17,500 | -16,296 | -15,265 | -13,534 |
| Other shareholders' equity | 11 | 10 | 11 | 3 | 14 |
| TOTAL | $5,009 | $4,917 | $4,011 | $5,034 | $6,782 |
| Total Liabilities And Equity | $6,385 | $6,653 | $5,900 | $7,412 | $8,567 |